Literature DB >> 15484294

Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.

Lin-Lang Guo1, Sha Xiao, Ying Guo.   

Abstract

AIM: To investigate the relationship between bcl-2 gene and its related protein bax and intrahepatic cholangiocellular carcinoma (CCC).
METHODS: Semi-nested in situ PCR (SNISPCR) and immunohistochemistry were performed to detect bcl-2/JH fusion gene and bcl-2, bax protein expression in 29 cases of CCC.
RESULTS: No bcl-2/JH fusion gene was found in all cases of CCC, 72.4% of 29 cases expressed bcl-2 protein. Bcl-2 protein expression was related to histopathological grades (P<0.05). There was no corresponding relationship between bcl-2/JH fusion gene formation and bcl-2 protein expression in CCC (P<0.05). Bax was expressed in 10.3% of 29 cases. The ratio of bcl-2 to bax in normal liver tissues (3.5 to 1) was different from that in tumor tissues (7.0 to 1).
CONCLUSION: It is suggested that bcl-2/JH fusion gene formation is not a frequent event and may not play an important role in the pathogenesis of CCC. However, aberrant ratio of bcl-2 to bax protein expression may be involved in the course of tumorigenesis of CCC. Abnormal bcl-2 protein expression may not be solely resulted from bcl-2/JH fusion gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15484294      PMCID: PMC4572289          DOI: 10.3748/wjg.v10.i22.3251

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis.

Authors:  H Perlman; X Zhang; M W Chen; K Walsh; R Buttyan
Journal:  Cell Death Differ       Date:  1999-01       Impact factor: 15.828

2.  The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.

Authors:  A C Aisenberg; B M Wilkes; J O Jacobson
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

3.  An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.

Authors:  D Huebner-Chan; B Fernandes; G Yang; M S Lim
Journal:  Mod Pathol       Date:  2001-10       Impact factor: 7.842

4.  The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.

Authors:  M Nolte; M Werner; W Spann; B Schnabel; R von Wasielewski; L Wilkens; K Hübner; R Fischer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.

Authors:  L L Loro; O K Vintermyr; P G Liavaag; R Jonsson; A C Johannessen
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

6.  The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

Authors:  L Nakopoulou; C Vourlakou; A Zervas; A Tzonou; H Gakiopoulou; M A Dimopoulos
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

7.  Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?

Authors:  G Lilling; H Hacohen; J Nordenberg; T Livnat; V Rotter; Y Sidi
Journal:  Cancer Lett       Date:  2000-12-08       Impact factor: 8.679

8.  bcl-2 protein in non-small-cell lung carcinoma.

Authors:  F Pezzella; H Turley; I Kuzu; M F Tungekar; M S Dunnill; C B Pierce; A Harris; K C Gatter; D Y Mason
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

9.  Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma.

Authors:  Q L Lu; G Elia; S Lucas; J A Thomas
Journal:  Int J Cancer       Date:  1993-01-02       Impact factor: 7.396

10.  Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.

Authors:  A Skopelitou; M Hadjiyannakis; V Alexopoulou; O Krikoni; S Kamina; N Agnantis
Journal:  Anticancer Res       Date:  1996 Mar-Apr       Impact factor: 2.480

View more
  3 in total

1.  Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest And Mitochondria-Mediated Apoptosis.

Authors:  Xiao-Mei Mao; Pan Zhou; Si-Yang Li; Xiao-Yun Zhang; Jin-Xing Shen; Qing-Xi Chen; Jiang-Xing Zhuang; Dong-Yan Shen
Journal:  Onco Targets Ther       Date:  2019-11-04       Impact factor: 4.147

2.  Altered expression of cellular Bcl-2 in the progression of hamster cholangiocarcinogenesis.

Authors:  Byung-Suk Jeon; Byung-Il Yoon
Journal:  ScientificWorldJournal       Date:  2012-04-30

3.  β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines.

Authors:  Chisato Narahara; Teerachat Saeheng; Wanna Chaijaroenkul; Shyam Prakash Dumre; Kesara Na-Bangchang; Juntra Karbwang
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.